Literature DB >> 35554640

Effects of ethnicity and socioeconomic status on surgical outcomes from inflammatory bowel disease.

Dimitrios Stamatiou1, David N Naumann1,2, Helen Foss1, Rishi Singhal3, Sharad Karandikar4.   

Abstract

PURPOSE: Evidence suggests that ethnicity and socioeconomic status of patients with chronic diseases influence their healthcare outcomes. The aim of this study was to assess the impact of these factors on the surgical outcome of patients with inflammatory bowel disease (IBD) over a 15-year period.
METHODS: A retrospective observational study investigated IBD patients operated on at an NHS Trust between 2000-2015, with follow-up data until 2020. Logistic regression models were used to determine the relationship between ethnic minority background and Index of Multiple Deprivation (IMD) on outcomes including requirement for intra-abdominal surgery, permanent stoma, re-do surgery and surgical complications, accounting for age, gender, smoking history and biologic treatment.
RESULTS: There were 1,620 patients (56.7% ulcerative colitis (UC) and 43.3% Crohn's disease (CD)). Median age was 32 years, and 49.6% were female. Patients with an ethnic minority background accounted for 20.6%. Within 5 years of first presentation, 369 patients required intra-abdominal surgery, 95 permanent stomas and 107 re-do surgery. For CD patients, younger age at diagnosis, female patients, those with an ethnic minority background, higher IMD quintile, smoking history and biologic treatment were more likely to have intra-abdominal surgery. Ethnic minority background and higher IMD score were further associated with surgical complications for CD but not UC patients.
CONCLUSION: Ethnic minority status and socioeconomic deprivation were associated with worse surgical outcomes within our cohort of IBD patients. These findings may stimulate discourse regarding the strategic planning of equitable healthcare services.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Ethnicity; Inflammatory bowel disease; Postoperative complications; Re-do surgery; Socioeconomic deprivation; Stoma; Surgery

Mesh:

Substances:

Year:  2022        PMID: 35554640     DOI: 10.1007/s00384-022-04180-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

Review 1.  Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.

Authors:  Alexandra D Frolkis; Jonathan Dykeman; María E Negrón; Jennifer Debruyn; Nathalie Jette; Kirsten M Fiest; Talia Frolkis; Herman W Barkema; Kevin P Rioux; Remo Panaccione; Subrata Ghosh; Samuel Wiebe; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2013-07-27       Impact factor: 22.682

Review 2.  A systematic review and meta-analysis of outcomes after elective surgery for ulcerative colitis.

Authors:  D M Baker; A-M Folan; M J Lee; G L Jones; S R Brown; A J Lobo
Journal:  Colorectal Dis       Date:  2020-09-01       Impact factor: 3.788

Review 3.  Epidemiology of inflammatory bowel disease.

Authors:  G Whelan
Journal:  Med Clin North Am       Date:  1990-01       Impact factor: 5.456

Review 4.  Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.

Authors:  E J Mao; G S Hazlewood; G G Kaplan; L Peyrin-Biroulet; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2016-11-10       Impact factor: 8.171

5.  Socioeconomic deprivation does not influence the severity of Crohn's disease: Results of a prospective multicenter study.

Authors:  Stéphane Nahon; Pierre Lahmek; Gilles Macaigne; Jean-Pierre Faurel; Catherine Sass; Mehran Howaizi; Antoine Fleury; A Baju; Christophe Locher; Georges Barjonet; GillesGatineau Saillant; Jean-Jacques Moulin; Cécile Poupardin
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

Review 6.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

Authors:  Siew C Ng; Hai Yun Shi; Nima Hamidi; Fox E Underwood; Whitney Tang; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Justin C Y Wu; Francis K L Chan; Joseph J Y Sung; Gilaad G Kaplan
Journal:  Lancet       Date:  2017-10-16       Impact factor: 79.321

7.  Impact of socioeconomic deprivation on short-term outcomes and long-term overall survival after colorectal resection for cancer.

Authors:  Chintamani Godbole; Aneel Bhangu; Douglas M Bowley; Thejasvi Subramanian; Sivesh K Kamarajah; Sharad Karandikar
Journal:  Int J Colorectal Dis       Date:  2019-11-12       Impact factor: 2.571

8.  The impact of ethnicity on clinical outcomes in COVID-19: A systematic review.

Authors:  Daniel Pan; Shirley Sze; Jatinder S Minhas; Mansoor N Bangash; Nilesh Pareek; Pip Divall; Caroline Ml Williams; Marco R Oggioni; Iain B Squire; Laura B Nellums; Wasim Hanif; Kamlesh Khunti; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-06-03

9.  Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study.

Authors:  Ravi Misra; Jimmy Limdi; Rachel Cooney; Samia Sakuma; Matthew Brookes; Edward Fogden; Sanjeev Pattni; Naveen Sharma; Tariq Iqbal; Pia Munkholm; Johan Burisch; Naila Arebi
Journal:  World J Gastroenterol       Date:  2019-10-28       Impact factor: 5.742

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  1 in total

Review 1.  Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review.

Authors:  Agata Michalak; Beata Kasztelan-Szczerbińska; Halina Cichoż-Lach
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.